Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans
about
Apolipoprotein A-V gene therapy for disease prevention / treatment:a critical analysisApolipoprotein E synthesized by adipocyte and apolipoprotein E carried on lipoproteins modulate adipocyte triglyceride contentAnti-inflammatory and cholesterol-reducing properties of apolipoprotein mimetics: a reviewThe atherogenic Scarb1 null mouse model shows a high bone mass phenotypeApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content.Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans.Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein EApolipoprotein A-V deficiency enhances chylomicron production in lymph fistula miceHepatic remnant lipoprotein clearance by heparan sulfate proteoglycans and low-density lipoprotein receptors depend on dietary conditions in miceSmall molecule antagonists of cell-surface heparan sulfate and heparin-protein interactions.The pathophysiology of intestinal lipoprotein production.Update on APOA5 Genetics: Toward a Better Understanding of Its Physiological Impact.Targeting heparin and heparan sulfate protein interactions.ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors.Aberrant hetero-disulfide bond formation by the hypertriglyceridemia-associated p.Gly185Cys APOA5 variant (rs2075291).Hepatic and Aortic Arch Expression and Serum Levels of Syndecan-1 in ApoE-/- Mice.Hepatitis B virus inhibits the in vivo and in vitro synthesis and secretion of apolipoprotein C3.Lipoprotein(a) Mass Levels Increase Significantly According to APOE Genotype: An Analysis of 431 239 Patients.Apolipoprotein C-II: New findings related to genetics, biochemistry, and role in triglyceride metabolism.Apolipoproteins E and CIII interact to regulate HDL metabolism and coronary heart disease risk.The Apolipoprotein E Mimetic Peptide AEM-2 Attenuates Mitochondrial Injury And Apoptosis In Human THP-1 Macrophages.
P2860
Q26775009-5D24E287-9FC9-450A-93BB-3166BC8AF11FQ34143697-5ADE0C85-8920-40ED-A26E-A0AD6B6822F6Q34238630-CB805C37-9A60-4C5B-99DA-72DCD5F22EACQ34386283-985CD362-C843-4426-A34D-93B5B0C11EB4Q35120896-5187C890-1E27-4AB6-918D-F7261F71F2BAQ35120945-B5E6E707-9EF5-401F-AB5D-F15633C5446BQ35153978-F0436E5D-01E4-4B78-91BA-AD98DD4684ECQ35274124-663C3B85-0B33-4498-B72B-CA8B3A53AE70Q37292212-1163E066-B5FC-409E-866A-017C9D68D97AQ37607660-03CF86E2-C321-43F1-A7D0-3649A33C2DD9Q38410893-F47B13C4-FE86-42C3-BC45-52A287540A7CQ39303512-4297B9B8-65BB-4C60-BB1A-9B2C9AC02242Q39399937-03202B6C-A32C-4994-BACA-1FB57E8EB92BQ39614082-771678C3-D34E-4ED1-ABA4-B7CAB640903AQ42134382-AAFAF68D-0EF5-496F-B8A2-2388574B50ABQ45158054-40D284DC-749D-4B83-9254-D57934A31E98Q45324907-3EDF8AD9-98AA-49FF-B53F-23F035467B69Q46239308-359299FA-2793-4A16-9044-3490849C621EQ50183430-B0EE17C1-E07B-4EB2-AB85-7408BD7941D0Q52375183-69AFD47F-74F9-4B08-B840-381F4AC34C5EQ55339879-CFBB2823-BC6D-4CDF-9931-288B2CB7C7F4
P2860
Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans
@en
type
label
Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans
@en
prefLabel
Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans
@en
P2093
P2860
P921
P356
P1476
Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans
@en
P2093
Erin M Foley
Jeffrey D Esko
Jon C Gonzales
P2860
P304
P356
10.1172/JCI67398
P407
P577
2013-05-08T00:00:00Z